Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients

AIDS. 2019 Aug 1;33(10):1673-1674. doi: 10.1097/QAD.0000000000002245.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Female
  • HIV Infections / drug therapy*
  • HIV Integrase Inhibitors / administration & dosage*
  • HIV Integrase Inhibitors / adverse effects*
  • Heterocyclic Compounds, 3-Ring / administration & dosage*
  • Heterocyclic Compounds, 3-Ring / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Oxazines
  • Piperazines
  • Pyridones
  • Weight Gain*

Substances

  • HIV Integrase Inhibitors
  • Heterocyclic Compounds, 3-Ring
  • Oxazines
  • Piperazines
  • Pyridones
  • dolutegravir